Cai H, Liu D, Xue W, Ma L, Xie H, Ning K
Transl Neurosci. 2024; 15(1):20220359.
PMID: 39654878
PMC: 11627081.
DOI: 10.1515/tnsci-2022-0359.
Sun M, Manson M, Guo T, de Lange E
CNS Drugs. 2024; 38(5):349-373.
PMID: 38580795
PMC: 11026214.
DOI: 10.1007/s40263-024-01082-3.
Huang C, Hoque T, Bendayan R
Front Pharmacol. 2023; 14:1118580.
PMID: 36969875
PMC: 10030948.
DOI: 10.3389/fphar.2023.1118580.
Banks W, Noonan C, Rhea E
Aging Pathobiol Ther. 2023; 4(4):100-108.
PMID: 36644126
PMC: 9837797.
DOI: 10.31491/apt.2022.12.100.
Zhao P, Zhang N, An Z
Antib Ther. 2022; 5(4):311-331.
PMID: 36540309
PMC: 9759110.
DOI: 10.1093/abt/tbac028.
Selection of single domain anti-transferrin receptor antibodies for blood-brain barrier transcytosis using a neurotensin based assay and histological assessment of target engagement in a mouse model of Alzheimer's related amyloid-beta pathology.
Su S, Esparza T, Brody D
PLoS One. 2022; 17(10):e0276107.
PMID: 36256604
PMC: 9578589.
DOI: 10.1371/journal.pone.0276107.
Discerning the Role of Blood Brain Barrier Dysfunction in Alzheimer's Disease.
Tao Q, Lin R, Chen Y, Wu Z
Aging Dis. 2022; 13(5):1391-1404.
PMID: 36186141
PMC: 9466977.
DOI: 10.14336/AD.2022.0130-1.
Nanogels as Novel Nanocarrier Systems for Efficient Delivery of CNS Therapeutics.
Zhang Y, Zou Z, Liu S, Miao S, Liu H
Front Bioeng Biotechnol. 2022; 10:954470.
PMID: 35928954
PMC: 9343834.
DOI: 10.3389/fbioe.2022.954470.
Increased/Targeted Brain (Pro)Drug Delivery via Utilization of Solute Carriers (SLCs).
Huttunen J, Adla S, Markowicz-Piasecka M, Huttunen K
Pharmaceutics. 2022; 14(6).
PMID: 35745806
PMC: 9228667.
DOI: 10.3390/pharmaceutics14061234.
Effects of genetic polymorphism of drug-metabolizing enzymes on the plasma concentrations of antiepileptic drugs in Chinese population.
Zhao W, Meng H
Bioengineered. 2022; 13(3):7709-7745.
PMID: 35290166
PMC: 9278974.
DOI: 10.1080/21655979.2022.2036916.
Natural Product-based Nanomedicine: Recent Advances and Issues for the Treatment of Alzheimer's Disease.
Woon C, Hui W, Abas R, Haron M, Das S, Lin T
Curr Neuropharmacol. 2021; 20(8):1498-1518.
PMID: 34923947
PMC: 9881085.
DOI: 10.2174/1570159X20666211217163540.
Neurosteroids: Structure-Uptake Relationships and Computational Modeling of Organic Anion Transporting Polypeptides (OATP)1A2.
Adla S, Tonduru A, Kronenberger T, Kudova E, Poso A, Huttunen K
Molecules. 2021; 26(18).
PMID: 34577133
PMC: 8472597.
DOI: 10.3390/molecules26185662.
Targeting Systems to the Brain Obtained by Merging Prodrugs, Nanoparticles, and Nasal Administration.
Botti G, Dalpiaz A, Pavan B
Pharmaceutics. 2021; 13(8).
PMID: 34452105
PMC: 8399330.
DOI: 10.3390/pharmaceutics13081144.
Role of microRNAs in glioblastoma.
Chen M, Medarova Z, Moore A
Oncotarget. 2021; 12(17):1707-1723.
PMID: 34434499
PMC: 8378762.
DOI: 10.18632/oncotarget.28039.
Regional Differences in Penetration of the Protein Stabilizer Trimethoprim (TMP) in the Rat Central Nervous System.
Ineichen B, Di Palma S, Laczko E, Liddelow S, Neumann S, Schwab M
Front Mol Neurosci. 2020; 13:167.
PMID: 33013318
PMC: 7496896.
DOI: 10.3389/fnmol.2020.00167.
Nanoparticle-Based Technology Approaches to the Management of Neurological Disorders.
Sim T, Tarini D, Dheen S, Bay B, Srinivasan D
Int J Mol Sci. 2020; 21(17).
PMID: 32842530
PMC: 7503838.
DOI: 10.3390/ijms21176070.
Targeting of Perforin Inhibitor into the Brain Parenchyma Via a Prodrug Approach Can Decrease Oxidative Stress and Neuroinflammation and Improve Cell Survival.
Tampio J, Huttunen J, Montaser A, Huttunen K
Mol Neurobiol. 2020; 57(11):4563-4577.
PMID: 32754897
PMC: 7515946.
DOI: 10.1007/s12035-020-02045-7.
Developmental patterns in human blood-brain barrier and blood-cerebrospinal fluid barrier ABC drug transporter expression.
Verscheijden L, van Hattem A, Pertijs J, de Jongh C, Verdijk R, Smeets B
Histochem Cell Biol. 2020; 154(3):265-273.
PMID: 32448916
PMC: 7502061.
DOI: 10.1007/s00418-020-01884-8.
Astrocyte-Targeted Transporter-Utilizing Derivatives of Ferulic Acid Can Have Multifunctional Effects Ameliorating Inflammation and Oxidative Stress in the Brain.
Montaser A, Huttunen J, Ibrahim S, Huttunen K
Oxid Med Cell Longev. 2019; 2019:3528148.
PMID: 31814871
PMC: 6877910.
DOI: 10.1155/2019/3528148.
Efficiency of Penetration of Dopamine and Serotonin Peptide Derivatives through the Artificial Membranes.
Shevchenko V, Andreeva L, Nagaev I, Shevchenko K, Myasoedov N
Dokl Biochem Biophys. 2019; 488(1):354-356.
PMID: 31768859
DOI: 10.1134/S1607672919050168.